Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Dublin, March 11, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/rhvbfw/metered_dose) has announced the addition of the "Metered Dose Inhalers to 2022" report to their offering.
This report examines the current and future metered dose inhalers market and the key topics all market participants should be aware of. Recent improvements in the control of the inspiry event have reduced the need for add-on devices designed to help regulate patient administration. Growth in upper airway therapeutics will help to push MDI unit demand to high single digits between now and the end of the decade.
Questions Answered:
- What inhalable drugs are supplied in MDIs, how are they marketed, what are the device specifics, and who markets them?
- What inhalable MDI products are in late stage development, who are the developers, and what indications are they targeting?
- What are the major factors driving metered dose inhaled drug/device demand?
- What is the size of the market today, who are the market share leaders, and what will the market share be in 2022?
- How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
- What are the essential design factors, material selection issues, technologies and market development issues MDI products?
- What are the significant economic, technology, and regulatory factors affecting the market for MDIs?
Report Structure:
1. Executive Summary
2. Inhaled Drug Delivery Market Dynamics
3. Devices and Formulations
4. MDI Technology Factors
5. MDI Performance Factors
6. MDI Product Assessments and Analysis
7. Therapeutic Market Analysis, Market Data and Forecasts
8. Market Factors
9. Company Profiles
For more information visit http://www.researchandmarkets.com/research/rhvbfw/metered_dose
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Inhalers and Nebulisers, Respiratory Devices
